Ameliora Wealth Management Ltd. Cuts Stake in MetLife, Inc. (NYSE:MET)

Ameliora Wealth Management Ltd. trimmed its position in shares of MetLife, Inc. (NYSE:METFree Report) by 34.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,409 shares of the financial services provider’s stock after selling 4,432 shares during the quarter. Ameliora Wealth Management Ltd.’s holdings in MetLife were worth $590,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Criterion Capital Advisors LLC acquired a new position in MetLife during the fourth quarter worth $26,000. GoalVest Advisory LLC raised its stake in shares of MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock worth $29,000 after buying an additional 165 shares during the last quarter. Tennessee Valley Asset Management Partners purchased a new stake in shares of MetLife in the fourth quarter valued at $34,000. Pineridge Advisors LLC purchased a new stake in MetLife during the 4th quarter worth $39,000. Finally, Bank & Trust Co bought a new position in shares of MetLife during the second quarter worth about $39,000. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Jefferies Financial Group lifted their target price on shares of MetLife from $83.00 to $86.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. JPMorgan Chase & Co. raised their price target on MetLife from $81.00 to $86.00 and gave the company an “overweight” rating in a report on Tuesday, July 2nd. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Morgan Stanley boosted their price objective on shares of MetLife from $82.00 to $83.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 10th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a research note on Monday, July 8th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $82.85.

Get Our Latest Research Report on MetLife

MetLife Price Performance

MET stock traded up $0.56 during midday trading on Tuesday, hitting $70.41. The company’s stock had a trading volume of 3,249,353 shares, compared to its average volume of 3,362,657. The company has a 50 day moving average of $71.66 and a two-hundred day moving average of $71.24. MetLife, Inc. has a 12 month low of $57.91 and a 12 month high of $79.34. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $50.07 billion, a price-to-earnings ratio of 24.20, a price-to-earnings-growth ratio of 0.65 and a beta of 1.11.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.15. The business had revenue of $17.82 billion for the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.94 earnings per share. On average, analysts expect that MetLife, Inc. will post 8.62 EPS for the current year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, August 6th. This represents a $2.18 annualized dividend and a dividend yield of 3.10%. MetLife’s payout ratio is 74.91%.

MetLife announced that its Board of Directors has authorized a share buyback plan on Wednesday, May 1st that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 6% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.